DNA cycle sequencing of a common restriction fragment of Staphylococcus aureus bacteriophages by capillary electrophoresis using replaceable linear polyacrylamide

Electrophoresis
K KlepárnikP Bocek

Abstract

The nucleotide sequence of a part of a 4.9 kbp common restriction fragment isolated from Staphylococcus aureus bacteriophage (bacterial virus) 3A has been determined by capillary electrophoresis (CE). The fast separation of sequencing fragments in linear polyacrylamide solution at a temperature of 55 degrees C allowed the reading of more than 650 bases of sequence in 60 min. The single strand (ss)DNA fragments were prepared by cycle sequencing with fluorescently labeled dideoxy-terminators on the cloned bacteriophage DNA template. With respect to analysis speed, sequence read-length, low sample consumption and automation, CE offers a simple, labor-saving and inexpensive procedure for DNA sequencing. Operating the CE columns at elevated temperature proved to be a rapid procedure capable of extending sequence read-length. The resulting sequence of the common restriction fragment can be used for the preparation of specific primers and oligonucleotide hybridization probes for identification of Staphylococcus aureus bacteriophages and/or prophages belonging to the bacteriophage species 3A.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Dec 1, 1991·Electrophoresis·P Bocek, A Chrambach
Sep 25, 1991·Nucleic Acids Research·A E KargerR F Gesteland
Mar 25, 1990·Nucleic Acids Research·H Swerdlow, R Gesteland
May 1, 1990·Analytical Chemistry·H DrossmanL M Smith
Jul 1, 1985·Journal of Virology·P R StewartP R Matthews
Sep 1, 1985·The Journal of General Virology·J S Lee, P R Stewart
Aug 1, 1985·Biopolymers·O J LumpkinB H Zimm
Oct 15, 1995·Analytical Chemistry·A T Woolley, R A Mathies
Sep 1, 1996·Electrophoresis·S MenchenB Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.